2014-2026 Global Exocrine Pancreatic Insufficiency Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

SKU ID :Maia-14763521 | Published Date: 10-Dec-2019 | No. of pages: 131
Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Exocrine Pancreatic Insufficiency Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Exocrine Pancreatic Insufficiency Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Exocrine Pancreatic Insufficiency Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Exocrine Pancreatic Insufficiency Market-Segmentation by Type 5.1 Pancreatic Enzyme Replacement Therapy (Creon, Zenpep, Pancreaze, Ultresa, Viokase, Pertzye) 5.2 Phase III Drugs 6 Global Exocrine Pancreatic Insufficiency Market-Segmentation by Application 6.1 Hospital Pharmacy 6.2 Retail Pharmacy 6.3 Online Sales 6.4 Others 7 Global Exocrine Pancreatic Insufficiency Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Janssen Pharmaceuticals Inc. 8.1.1 Janssen Pharmaceuticals Inc. Profile 8.1.2 Janssen Pharmaceuticals Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Janssen Pharmaceuticals Inc. Product/Solution Launches and Enhancements Analysis 8.1.4 Janssen Pharmaceuticals Inc. Business Overview/Recent Development/Acquisitions 8.2 Anthera Pharmaceuticals Inc. 8.2.1 Anthera Pharmaceuticals Inc. Profile 8.2.2 Anthera Pharmaceuticals Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Anthera Pharmaceuticals Inc. Product/Solution Launches and Enhancements Analysis 8.2.4 Anthera Pharmaceuticals Inc. Business Overview/Recent Development/Acquisitions 8.3 Abbvie Inc. 8.3.1 Abbvie Inc. Profile 8.3.2 Abbvie Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Abbvie Inc. Product/Solution Launches and Enhancements Analysis 8.3.4 Abbvie Inc. Business Overview/Recent Development/Acquisitions 8.4 Cilian AG 8.4.1 Cilian AG Profile 8.4.2 Cilian AG Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Cilian AG Product/Solution Launches and Enhancements Analysis 8.4.4 Cilian AG Business Overview/Recent Development/Acquisitions 8.5 Digestive Care, Inc. 8.5.1 Digestive Care, Inc. Profile 8.5.2 Digestive Care, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Digestive Care, Inc. Product/Solution Launches and Enhancements Analysis 8.5.4 Digestive Care, Inc. Business Overview/Recent Development/Acquisitions 8.6 Nordmark Arzneimittel GmbH & Co. KG 8.6.1 Nordmark Arzneimittel GmbH & Co. KG Profile 8.6.2 Nordmark Arzneimittel GmbH & Co. KG Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Nordmark Arzneimittel GmbH & Co. KG Product/Solution Launches and Enhancements Analysis 8.6.4 Nordmark Arzneimittel GmbH & Co. KG Business Overview/Recent Development/Acquisitions 8.7 AzurRx BioPharma, Inc. 8.7.1 AzurRx BioPharma, Inc. Profile 8.7.2 AzurRx BioPharma, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 AzurRx BioPharma, Inc. Product/Solution Launches and Enhancements Analysis 8.7.4 AzurRx BioPharma, Inc. Business Overview/Recent Development/Acquisitions 8.8 Allergan plc. 8.8.1 Allergan plc. Profile 8.8.2 Allergan plc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Allergan plc. Product/Solution Launches and Enhancements Analysis 8.8.4 Allergan plc. Business Overview/Recent Development/Acquisitions 9 Global Exocrine Pancreatic Insufficiency Market-Segmentation by Geography 10 North America 10.1 North America Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E 10.4 North America Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E 10.5 North America Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E 10.6 North America Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E) 10.7 North America Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Exocrine Pancreatic Insufficiency by Country (United States, Canada) 10.8.1 North America Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E) 10.8.2 North America Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E) 10.9 North America Exocrine Pancreatic Insufficiency Market PEST Analysis 11 Europe 11.1 Europe Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E 11.4 Europe Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E 11.5 Europe Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E 11.6 Europe Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Exocrine Pancreatic Insufficiency by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E) 11.8.2 Europe Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E) 11.9 Europe Exocrine Pancreatic Insufficiency Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E 12.4 Asia-Pacific Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E 12.6 Asia-Pacific Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Exocrine Pancreatic Insufficiency by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Exocrine Pancreatic Insufficiency Market PEST Analysis 13 Latin America 13.1 Latin America Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E 13.4 Latin America Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E 13.5 Latin America Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E 13.6 Latin America Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Exocrine Pancreatic Insufficiency by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E) 13.8.2 Latin America Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E) 13.9 Latin America Exocrine Pancreatic Insufficiency Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E 14.4 Middle East & Africa Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E 14.6 Middle East & Africa Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Exocrine Pancreatic Insufficiency by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Exocrine Pancreatic Insufficiency Market PEST Analysis 15 Future Forecast of the Global Exocrine Pancreatic Insufficiency Market from 2018-2026 15.1 Future Forecast of the Global Exocrine Pancreatic Insufficiency Market from 2019-2026 Segment by Region 15.2 Global Exocrine Pancreatic Insufficiency Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source
List of Tables and Figures Global Exocrine Pancreatic Insufficiency Market Value ($) and Growth Rate of Exocrine Pancreatic Insufficiency from 2014-2026 Global Exocrine Pancreatic Insufficiency Production and Growth Rate Segment by Product Type from 2014-2026F Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Segment by Application from 2014-2019E Figure Exocrine Pancreatic Insufficiency Picture Table Product Specifications of Exocrine Pancreatic Insufficiency Table Driving Factors for this Market Table Industry News of Exocrine Pancreatic Insufficiency Market Figure Value Chain Status of Exocrine Pancreatic Insufficiency Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Exocrine Pancreatic Insufficiency Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Exocrine Pancreatic Insufficiency Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Pancreatic Enzyme Replacement Therapy (Creon, Zenpep, Pancreaze, Ultresa, Viokase, Pertzye) of Exocrine Pancreatic Insufficiency Figure Phase III Drugs of Exocrine Pancreatic Insufficiency Table Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Exocrine Pancreatic Insufficiency Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hospital Pharmacy of Exocrine Pancreatic Insufficiency Figure Retail Pharmacy of Exocrine Pancreatic Insufficiency Figure Online Sales of Exocrine Pancreatic Insufficiency Figure Others of Exocrine Pancreatic Insufficiency Table Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Exocrine Pancreatic Insufficiency Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Exocrine Pancreatic Insufficiency Figure Online Channel of Exocrine Pancreatic Insufficiency Table Janssen Pharmaceuticals Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Janssen Pharmaceuticals Inc. Sales and Growth Rate from 2014-2019E Figure Janssen Pharmaceuticals Inc. Revenue ($) and Global Market Share from 2014-2019E Table Janssen Pharmaceuticals Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E) Table Anthera Pharmaceuticals Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Anthera Pharmaceuticals Inc. Sales and Growth Rate from 2014-2019E Figure Anthera Pharmaceuticals Inc. Revenue ($) and Global Market Share from 2014-2019E Table Anthera Pharmaceuticals Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E) Table Abbvie Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Abbvie Inc. Sales and Growth Rate from 2014-2019E Figure Abbvie Inc. Revenue ($) and Global Market Share from 2014-2019E Table Abbvie Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E) Table Cilian AG Profile (Company Name, Plants Distribution, Sales Region) Figure Cilian AG Sales and Growth Rate from 2014-2019E Figure Cilian AG Revenue ($) and Global Market Share from 2014-2019E Table Cilian AG Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E) Table Digestive Care, Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Digestive Care, Inc. Sales and Growth Rate from 2014-2019E Figure Digestive Care, Inc. Revenue ($) and Global Market Share from 2014-2019E Table Digestive Care, Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E) Table Nordmark Arzneimittel GmbH & Co. KG Profile (Company Name, Plants Distribution, Sales Region) Figure Nordmark Arzneimittel GmbH & Co. KG Sales and Growth Rate from 2014-2019E Figure Nordmark Arzneimittel GmbH & Co. KG Revenue ($) and Global Market Share from 2014-2019E Table Nordmark Arzneimittel GmbH & Co. KG Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E) Table AzurRx BioPharma, Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure AzurRx BioPharma, Inc. Sales and Growth Rate from 2014-2019E Figure AzurRx BioPharma, Inc. Revenue ($) and Global Market Share from 2014-2019E Table AzurRx BioPharma, Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E) Table Allergan plc. Profile (Company Name, Plants Distribution, Sales Region) Figure Allergan plc. Sales and Growth Rate from 2014-2019E Figure Allergan plc. Revenue ($) and Global Market Share from 2014-2019E Table Allergan plc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Exocrine Pancreatic Insufficiency Production Value ($) by Region from 2014-2019E Table Global Exocrine Pancreatic Insufficiency Production Value Share by Region from 2014-2019E Table Global Exocrine Pancreatic Insufficiency Production by Region from 2014-2019E Table Global Exocrine Pancreatic Insufficiency Consumption Value ($) by Region from 2014-2019E Table Global Exocrine Pancreatic Insufficiency Consumption by Region from 2014-2019E Table North America Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E Table North America Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E) Table North America Exocrine Pancreatic Insufficiency Production by Type (2014-2019E) Table North America Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E) Table North America Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E) Table North America Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E) Figure North America Exocrine Pancreatic Insufficiency Market PEST Analysis Table Europe Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E Table Europe Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E) Table Europe Exocrine Pancreatic Insufficiency Production by Type (2014-2019E) Table Europe Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E) Table Europe Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E) Table Europe Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E) Figure Europe Exocrine Pancreatic Insufficiency Market PEST Analysis Table Asia-Pacific Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E Table Asia-Pacific Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E) Table Asia-Pacific Exocrine Pancreatic Insufficiency Production by Type (2014-2019E) Table Asia-Pacific Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E) Table Asia-Pacific Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E) Table Asia-Pacific Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Exocrine Pancreatic Insufficiency Market PEST Analysis Table Latin America Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E Table Latin America Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E) Table Latin America Exocrine Pancreatic Insufficiency Production by Type (2014-2019E) Table Latin America Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E) Table Latin America Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E) Table Latin America Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E) Figure Latin America Exocrine Pancreatic Insufficiency Market PEST Analysis Table Middle East & Africa Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E Table Middle East & Africa Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E) Table Middle East & Africa Exocrine Pancreatic Insufficiency Production by Type (2014-2019E) Table Middle East & Africa Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E) Table Middle East & Africa Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E) Table Middle East & Africa Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Exocrine Pancreatic Insufficiency Market PEST Analysis Table Global Exocrine Pancreatic Insufficiency Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Exocrine Pancreatic Insufficiency Production and Growth Rate Forecast by Region (2019-2026) Table Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Exocrine Pancreatic Insufficiency Production and Growth Rate Forecast by Type (2019-2026) Table Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Forecast by Application (2019-2026)
  • PRICE
  • $3460
    $5000

Our Clients